Autor: "Lamm W" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: High fibrinogen levels are associated with poor survival in patients with liposarcoma.
Autorzy:: Peschek LS; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Hobusch GM; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. .
Funovics PT; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Willegger M; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Schmid MP; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
Amann G; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.
Lamm W; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Brodowicz T; Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria.
Ay C; Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Windhager R; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Panotopoulos J; Department of Orthopaedics, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 May 27; Vol. 13 (1), pp. 8608. Date of Electronic Publication: 2023 May 27.
Typ publikacji:: Journal Article
MeSH Terms:: Liposarcoma*
Sarcoma*
Hemostatics*
Humans ; Retrospective Studies ; Prognosis ; Fibrinogen/metabolism ; Proportional Hazards Models ; Kaplan-Meier Estimate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: R-ICE Chemotherapy with or without Autologous Transplantation for Elderly Patients with Relapsed or Refractory Aggressive B-Cell Lymphomas.
Autorzy:: Turki AT
Lamm W
Liebregts T
Dührsen U; Pokaż więcej
Źródło:: Oncology research and treatment [Oncol Res Treat] 2018; Vol. 41 (9), pp. 534-538. Date of Electronic Publication: 2018 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma, B-Cell/*therapy
Neoplasm Recurrence, Local/*therapy
Stem Cell Transplantation/*methods
Aged ; Carboplatin/therapeutic use ; Drug Resistance, Neoplasm ; Etoposide/therapeutic use ; Female ; Humans ; Ifosfamide/therapeutic use ; Kaplan-Meier Estimate ; Lymphoma, B-Cell/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Retrospective Studies ; Rituximab/therapeutic use ; Survival Rate ; Transplantation, Autologous/methods

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Prognostic Value of C-Reactive Protein Serum Levels in Patients with Uterine Leiomyosarcoma.
Autorzy:: Schwameis R; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Grimm C; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Petru E; Department of Obstetrics and Gynaecology of the Medical University of Graz, Graz, Austria.
Natter C; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Staudigl C; Department of Gynaecology, Barmherzige Schwestern Hospital Linz, Linz, Austria.
Lamm W; Clinical Division of Oncology, Department of Medicine 1, Comprehensive Cancer Cente, Medical University Vienna, Vienna, Austria.
Koelbl H; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Krainer M; Clinical Division of Oncology, Department of Medicine 1, Comprehensive Cancer Cente, Medical University Vienna, Vienna, Austria.
Brodowicz T; Clinical Division of Oncology, Department of Medicine 1, Comprehensive Cancer Cente, Medical University Vienna, Vienna, Austria.
Reinthaller A; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Karl Landsteiner Institute for General Gynecology and Experimental Gynecologic Oncology, Vienna, Austria.
Polterauer S; Department of General Gynaecology and Gynaecological Oncology, Gynecologic Cancer Unit, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Aug 06; Vol. 10 (8), pp. e0133838. Date of Electronic Publication: 2015 Aug 06 (Print Publication: 2015).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: C-Reactive Protein/*analysis
Leiomyosarcoma/*diagnosis
Uterine Neoplasms/*diagnosis
Adult ; Biomarkers, Tumor/blood ; Female ; Humans ; Leiomyosarcoma/mortality ; Leiomyosarcoma/pathology ; Middle Aged ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Survival Rate ; Uterine Neoplasms/mortality ; Uterine Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Distinctive outcome in patients with non-uterine and uterine leiomyosarcoma.
Autorzy:: Lamm W
Natter C
Schur S
Köstler WJ
Reinthaller A
Krainer M
Grimm C
Horvath R
Amann G
Funovics P
Brodowicz T
Polterauer S; Department of Gynecology and Gynecologic Oncology, Medical University of Vienna, 18-20 Waehringer Guertel, 1090 Vienna, Austria. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2014 Dec 18; Vol. 14, pp. 981. Date of Electronic Publication: 2014 Dec 18.
Typ publikacji:: Journal Article
MeSH Terms:: Leiomyosarcoma/*mortality
Leiomyosarcoma/*pathology
Sarcoma/*mortality
Sarcoma/*pathology
Uterine Neoplasms/*mortality
Uterine Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Leiomyosarcoma/diagnosis ; Leiomyosarcoma/epidemiology ; Leiomyosarcoma/therapy ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Staging ; Patient Outcome Assessment ; Prognosis ; Retrospective Studies ; Sarcoma/diagnosis ; Sarcoma/epidemiology ; Sarcoma/therapy ; Survival Analysis ; Tomography, X-Ray Computed ; Tumor Burden ; Uterine Neoplasms/diagnosis ; Uterine Neoplasms/epidemiology ; Uterine Neoplasms/therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Circulating endothelial progenitor cells in castration resistant prostate cancer: a randomized, controlled, biomarker study.
Autorzy:: Fuereder T; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Wacheck V; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Strommer S; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Horak P; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Gerschpacher M; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Lamm W; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Kivaranovic D; Section for Medical Statistics, Medical University of Vienna, Vienna, Austria.
Krainer M; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2014 Apr 22; Vol. 9 (4), pp. e95310. Date of Electronic Publication: 2014 Apr 22 (Print Publication: 2014).
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Cell Movement*/drug effects
Biomarkers, Tumor/*metabolism
Endothelial Progenitor Cells/*pathology
Prostatic Neoplasms, Castration-Resistant/*pathology
Aged ; Bone and Bones/diagnostic imaging ; Bone and Bones/drug effects ; Bone and Bones/pathology ; Disease-Free Survival ; Docetaxel ; Endothelial Progenitor Cells/drug effects ; Humans ; Kinetics ; Male ; Middle Aged ; Prostate-Specific Antigen/metabolism ; Prostatic Neoplasms, Castration-Resistant/diagnostic imaging ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Radiography ; Taxoids/pharmacology ; Taxoids/therapeutic use